The new National Institutes of Health chief declared Friday that the Trump administration won't pursue lockdowns in future pandemics and his agency has stopped all forms of dangerous gain-of-function ...

THE HERITAGE FOUNDATION: Since the outbreak of COVID-19, new scientific analyses and insider accounts have revealed major vulnerabilities in how the United States oversees high-risk biological ...

(via The Heritage Foundation) Since the outbreak of COVID-19, new scientific analyses and insider accounts have revealed major vulnerabilities in how the United States oversees high-risk biological ...

Leading experts will explore the scientific and national security implications of gain-of-function research, highlight weaknesses in current oversight, and discuss realistic reforms in how the United ...

We preselected all newsletters you had before unsubscribing.

“Gain of function” (GoF) research refers to genetic modification that deliberately enhances the abilities of an organism — often a virus or bacterium — to study how such changes affect its function, ...

Gain-of-function (GOF) mutations in STAT1 cause a combined immunodeficiency characterized by chronic mucocutaneous candidiasis (CMC), recurrent infections, and autoimmunity. Mutations in the ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews. In this work, the authors aim to improve upon their previous ...

Proteins play a critical role in cellular function by interacting with other biomolecules; missense variants that cause loss of protein function can lead to a broad spectrum of genetic disorders.

Stanley is an associate professor and Richard and Rhoda Goldman distinguished chair in the biological sciences as well as faculty director for the Alliance for Global Health and Science at the ...

Add Yahoo as a preferred source to see more of our stories on Google. CNP/AdMedia/SIPA/Newscom Biosafety hawks were initially optimistic that the incoming second ...

Biosafety hawks were initially optimistic that the incoming second Trump administration would at last place binding constraints on so-called "dangerous gain-of-function" research, in which pathogens ...